Panbela Therapeutics (PBLA) Stock Chart & Stock Price History → Fidelity, Bezos, Goldman Bet Big on Tiny Biotech (From Behind the Markets) (Ad) Free PBLA Stock Alerts $0.38 +0.00 (+1.05%) (As of 11:10 AM ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Panbela Therapeutics Stock Price Performance5 Day Performance-7.12%1 Month Performance-30.17%3 Month Performance-66.58%6 Month Performance-97.16%Year-To-Date Performance-97.92%1 Year Performance-99.87% Receive PBLA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Panbela Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad The Tomorrow InvestorThe Department of Defense Has a New Drone ContractorThe Department of Defense just granted a major advantage to a small UAV provider. Since 1998, this Nasdaq-listed company has been supplying drones for civilian, enterprise, and military purposes.Click here to see how to invest PBLA Stock Chart for Wednesday, May, 8, 2024 PBLA Chart by TradingView Panbela Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/07/2024$0.41$0.38-6.85%$0.41$0.3811,969 shs$1.33 million05/06/2024$0.41$0.41-0.29%$0.42$0.3826,024 shs$1.42 million05/03/2024$0.38$0.41+7.58%$0.48$0.3949,422 shs$1.43 million05/02/2024$0.41$0.38-7.00%$0.48$0.3861,762 shs$1.33 million05/01/2024$0.43$0.41-4.65%$0.44$0.4050,329 shs$1.43 million04/30/2024$0.44$0.43-1.21%$0.44$0.4025,577 shs$1.50 million Get the Latest News and Ratings for PBLA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Panbela Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 04/29/2024$0.41$0.44+6.16%$0.49$0.4070,416 shs$1.52 million04/26/2024$0.44$0.41-6.82%$0.43$0.3548,233 shs$1.43 million04/25/2024$0.41$0.44+7.29%$0.48$0.4125,779 shs$1.53 million04/24/2024$0.42$0.41-2.36%$0.49$0.4114,382 shs$1.43 million04/23/2024$0.47$0.42-11.54%$0.45$0.4063,942 shs$1.46 million04/22/2024$0.42$0.47+13.05%$0.48$0.4019,649 shs$1.65 million04/19/2024$0.49$0.42-14.20%$0.49$0.40263,022 shs$1.46 million04/18/2024$0.52$0.49-5.14%$0.51$0.4666,294 shs$1.70 million04/17/2024$0.53$0.52-1.71%$0.55$0.4856,724 shs$1.80 million04/16/2024$0.54$0.53-2.78%$0.59$0.5237,903 shs$1.83 million04/15/2024$0.59$0.54-8.47%$0.59$0.5078,607 shs$1.88 million04/12/2024$0.58$0.59+1.72%$0.60$0.49142,976 shs$2.05 million04/11/2024$0.55$0.58+5.45%$0.60$0.5160,164 shs$2.02 million04/10/2024$0.55$0.55$0.63$0.5149,072 shs$1.91 million04/09/2024$0.55$0.55+0.80%$0.58$0.5346,884 shs$1.91 million04/08/2024$0.57$0.55-4.78%$0.63$0.5238,854 shs$1.90 million04/05/2024$0.57$0.57-0.17%$0.63$0.5377,757 shs$1.99 million04/04/2024$0.55$0.57+4.36%$0.60$0.5347,398 shs$2.00 million04/03/2024$0.55$0.55$0.63$0.5295,268 shs$1.92 million04/02/2024$0.55$0.55$0.60$0.51137,673 shs$1.91 million04/01/2024$0.67$0.55-17.91%$0.69$0.50137,673 shs$1.91 million03/29/2024$0.67$0.67$0.69$0.6092,549 shs$2.33 million03/28/2024$0.67$0.67-0.71%$0.69$0.6092,549 shs$2.33 million03/27/2024$0.64$0.67+5.44%$0.68$0.6199,445 shs$2.35 million03/26/2024$0.64$0.64$0.70$0.6138,182 shs$2.23 million03/25/2024$0.63$0.64+1.59%$0.67$0.6227,033 shs$2.23 million03/22/2024$0.67$0.63-6.12%$0.67$0.6111,272 shs$2.19 million03/21/2024$0.67$0.67+0.37%$0.70$0.6229,757 shs$2.34 million03/20/2024$0.63$0.67+6.13%$0.70$0.6010,965 shs$2.33 million03/19/2024$0.62$0.63+1.20%$0.70$0.6223,999 shs$2.19 million03/18/2024$0.60$0.62+3.75%$0.69$0.6033,694 shs$2.17 million03/15/2024$0.60$0.60$0.67$0.5666,666 shs$156,000.0003/14/2024$0.65$0.60-7.69%$0.66$0.5666,666 shs$154,000.0003/13/2024$0.67$0.65-2.99%$0.70$0.6084,717 shs$169,000.00BREAKING – Pentagon to Spend $20 Billion on “Distributed AI” (Ad)BREAKING - Pentagon to Spend $20 Billion on "Distributed AI" The U.S. Space Force calls it a "game changer." And one tiny firm is poised to win the contract to build it.Discover the name and ticker of this $2 stock here >>>03/12/2024$0.75$0.67-10.67%$0.78$0.60155,824 shs$174,000.0003/11/2024$0.56$0.75+35.14%$0.83$0.45305,000 shs$195,000.0003/08/2024$0.69$0.56-19.55%$0.69$0.41527,204 shs$144,000.0003/07/2024$1.11$0.69-37.85%$0.95$0.631.25 million shs$179,000.0003/06/2024$1.23$1.11-9.76%$1.28$1.08950,469 shs$289,000.0003/05/2024$1.22$1.23+0.82%$1.26$1.20237,200 shs$320,000.0003/04/2024$1.27$1.22-3.94%$1.30$1.19382,347 shs$312,000.0003/01/2024$1.18$1.27+7.63%$1.32$1.16532,101 shs$330,000.0002/29/2024$1.19$1.18-0.84%$1.26$1.14362,642 shs$302,000.0002/28/2024$1.23$1.19-3.25%$1.26$1.17322,786 shs$309,000.0002/27/2024$1.15$1.23+6.96%$1.24$1.15644,026 shs$320,000.0002/26/2024$1.12$1.15+2.68%$1.17$1.10354,671 shs$299,000.0002/23/2024$1.11$1.12+0.90%$1.14$1.09255,075 shs$291,000.0002/22/2024$1.15$1.11-3.48%$1.17$1.10321,506 shs$289,000.0002/21/2024$1.18$1.15-2.54%$1.20$1.13265,611 shs$299,000.0002/20/2024$1.25$1.18-5.60%$1.25$1.15574,815 shs$307,000.0002/19/2024$1.25$1.25$1.31$1.23397,300 shs$320,000.0002/16/2024$1.27$1.25-1.57%$1.31$1.23387,204 shs$325,000.0002/15/2024$1.36$1.27-6.62%$1.41$1.211.28 million shs$325,000.0002/14/2024$1.13$1.36+20.35%$1.49$1.124.00 million shs$348,000.0002/13/2024$1.17$1.13-3.42%$1.17$1.12251,914 shs$294,000.0002/12/2024$1.24$1.17-5.65%$1.24$1.15502,203 shs$304,000.0002/09/2024$1.14$1.24+8.77%$1.26$1.10548,943 shs$322,000.0002/08/2024$1.16$1.14-1.72%$1.17$1.08356,528 shs$296,000.0002/07/2024$1.20$1.16-3.33%$1.20$1.10380,700 shs$302,000.00 Related Companies: Histogen Stock Chart Lucy Scientific Discovery Stock Chart NeuBase Therapeutics Stock Chart GRI Bio Stock Chart InMed Pharmaceuticals Stock Chart Comera Life Sciences Stock Chart Galmed Pharmaceuticals Stock Chart 180 Life Sciences Stock Chart PainReform Stock Chart Qualigen Therapeutics Stock Chart Receive PBLA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Panbela Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:PBLA) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorFidelity, Bezos, Goldman Bet Big on Tiny BiotechBehind the MarketsElon Musk Secret Crypto Plot ExposedCrypto 101 MediaAI “wealth window” is closing June 25thParadigm PressShocking: One AI startup's revenue could surge 4,735%Manward PressGold Set to EXPLODE!Gold Safe ExchangeThe AI Stock that’s Disrupting Every IndustryStockEarningsThe #1 lithium battery stock to have on your radar in 2024!Smallcaps Daily Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Panbela Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.